Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies

To find metastatic recurrence biomarkers of triple-negative breast cancer (TNBC) treated by neoadjuvant chemotherapy and anti-EGFR antibodies (NAT), we evaluated tumor genomic, transcriptomic, and immune features, using MSK-IMPACT assay, gene arrays, Nanostring technology, and TIL assessment on H&am...

Descripción completa

Detalles Bibliográficos
Autores principales: Radosevic-Robin, Nina, Selenica, Pier, Zhu, Yingjie, Won, Helen H., Berger, Michael F., Ferrando, Lorenzo, Cocco, Emiliano, Privat, Maud, Ponelle-Chachuat, Flora, Abrial, Catherine, Nabholtz, Jean-Marc, Penault-Llorca, Frederique, Reis-Filho, Jorge S., Scaltriti, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448841/
https://www.ncbi.nlm.nih.gov/pubmed/34535679
http://dx.doi.org/10.1038/s41523-021-00334-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448841/
https://www.ncbi.nlm.nih.gov/pubmed/34535679
http://dx.doi.org/10.1038/s41523-021-00334-5

Ejemplares similares